Porcine Vaccines Market Research Report – Global Forecast till 2027

Porcine Vaccines Market Research Report: by Type (Inactivated Vaccines, DNA Vaccines), by Disease Indication (Diarrhea, Swine Influenza), By End User - Global Forecast Till 2027

ID: MRFR/HC/5969-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Global porcine vaccines market is expected to grow significantly over the forecast period. The global porcine vaccines market held a market value of USD 1910.7 million in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period. Porcine vaccine is an administrative and clinical drug which helps in improving swine health and protects against deadly viruses and pathogens. Porcine vaccines offer wide range of benefits for the treatment of swine diseases. The rising incidences of swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. is expected to boost the growth of the market over the forecast period. Moreover, rising number of biotechnology companies, research organizations engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector and rising demand for porcine meat and gelatine are driving the growth of this market. For instance, European Union is the third country in the world by per-capita pig meat consumption, with an average of 88.9 kilos of meat consumed in 2017. Despite the drivers, the high storage cost of vaccines may hinder the market growth during the assessment period.


Segmentation


The global porcine vaccines market has been segmented into type, disease indication, and end user.


By type, the market has been segmented into Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines.


On the basis of disease indication, the market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.


The market, by end user, has been segmented into Veterinary Hospitals and Hog Production Farm.


The global porcine vaccines market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The porcine vaccines market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European porcine vaccines market has been segmented into Western Europe and Eastern Europe. The Western Europe porcine vaccines market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The porcine vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The porcine vaccines market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Porcine Vaccines Systems Share (%), by Region, 2017


Porcine Vaccines Market


Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global porcine vaccines market owing to the rise in number of pig farms and rise in swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. Moreover, rapid increase in contract farming and independent farming for pig cultivation is driving the growth of this market in this region. According to a report from National Hog Farmer, there were 71.7 million pigs in US hog farms as of June 2016.


Europe is expected to hold the second largest position in the global porcine vaccines market. The market growth in this region is attributed to increasing number of production units for swine and high consumption of pork meat.


The porcine vaccines market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to initiatives by various government agencies, animal associations, and high growth opportunities for major key players for setting up their vaccine manufacturing plants in this region.


The Middle East & Africa has the lowest share of the global porcine market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the animal care sector.


Global Porcine Vaccines Market, by Type



  •  Inactivated vaccines

  • Live attenuated vaccines

  • Toxoid vaccines

  • Recombinant vaccines

  • Conjugate vaccines

  • DNA vaccines


Global Porcine Vaccines Market, by Disease Indication



  • PED (Porcine Epidemic Diarrhea)

  • PRRS (Porcine Reproductive & Respiratory Syndrome)

  • Swine influenza

  • Aujeszky's disease (AD)

  • Porcine Circovirus Associated Disease (PCVAD)

  • Others


Global Porcine Vaccines Market, by End-user



  • Veterinary Hospitals

  • Hog Production Farm


Global Porcine Vaccines Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Global Porcine Vaccines Market, by Key Players



  • Bayer AG

  •  Bimeda, Inc.

  •  Boehringer Ingelheim International GmbH

  • Ceva Sante Animale

  • Eli Lilly and Company

  • Merck & Co., Inc.

  • Sanofi S.A.

  • Vetoquinol S.A.

  • Zoetis, Inc.

  • PBS Animal Health

  • Aptimmune


Intended Audience



  • Porcine vaccines manufacturers

  • Porcine vaccines suppliers

  • Private research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Government research laboratories

  • Contract manufacturing organizations



Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Porcine Vaccines Market , by Type

6.1 Introduction

6.2 Inactivated Vaccines

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Live Attenuated Vaccines

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Toxoid Vaccines

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Recombinant Vaccines

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Conjugate Vaccines

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 DNA Vaccines

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027


Chapter 7. Global Porcine Vaccines Market , by Disease Indication

7.1 Introduction

7.2 PED (Porcine Epidemic Diarrhea)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 PRRS (Porcine Reproductive & Respiratory Syndrome)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Swine influenza

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Aujeszky's disease (AD)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Porcine Circovirus Associated Disease (PCVAD)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Chapter 8. Global Porcine Vaccines Market , by End User

8.1 Introduction

8.2 Veterinary Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Hog Production Farms

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Porcine Vaccines Market , by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Bayer AG

11.1.1 Company Overview

11.1.2 Treatment Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Bimeda, Inc.

11.2.1 Company Overview

11.2.2 Treatment Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Boehringer Ingelheim International GmbH

11.3.1 Company Overview

11.3.2 Treatment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Ceva Sante Animale

11.4.1 Company Overview

11.4.2 Treatment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Eli Lilly and Company

11.5.1 Company Overview

11.5.2 Treatment Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Merck & Co.,Inc.

11.6.1 Company Overview

11.6.2 Treatment Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Sanofi S.A.

11.7.1 Overview

11.7.2 Treatment Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

12.8 Vetoquinol S.A.

11.8.1 Overview

11.8.2 Treatment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Zoetis, Inc.

11.9.1 Overview

11.9.2 Treatment Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 PBS Animal Health

11.10.1 Overview

11.10.2 Treatment Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Aptimmune

11.11.1 Overview

11.11.2 Treatment Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Porcine Vaccines Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Porcine Vaccines Market Synopsis, 2020-2027

Table 2 Global Porcine Vaccines Market Estimates and Forecast, 2020-2027

(USD Million)

Table 3 Global Porcine Vaccines Market , by Region, 2020-2027 (USD Million)

Table 4 Global Porcine Vaccines Market , by Type, 2020-2027 (USD Million)

Table 5 Global Porcine Vaccines Market , by Disease Indication, 2020-2027 (USD

Million)

Table 6 Global Porcine Vaccines Market , by End User, 2020-2027 (USD Million)

Table 7 North America: Porcine Vaccines Market , by Type, 2020-2027 (USD

Million)

Table 9 North America: Porcine Vaccines Market , by Disease Indication, 2020-2027

(USD Million)

Table 10 North America: Porcine Vaccines Market , by End User, 2020-2027 (USD

Million)

Table 11 US: Porcine Vaccines Market , by Type, 2020-2027 (USD Million)

Table 13 US: Porcine Vaccines Market , by Disease Indication, 2020-2027 (USD

Million)

Table 14 US: Porcine Vaccines Market , by End User, 2020-2027 (USD Million)

Table 15 Canada: Porcine Vaccines Market , by Type, 2020-2027 (USD Million)

Table 17 Canada: Porcine Vaccines Market , by Disease Indication, 2020-2027 (USD

Million)

Table 18 Canada: Porcine Vaccines Market ,by End User, 2020-2027 (USD Million)

Table 20 Latin America: Porcine Vaccines Market , by Type, 2020-2027 (USD

Million)

Table 21 Latin America: Porcine Vaccines Market , by Disease Indication, 2018–

2023 (USD Million)

Table 22 Latin America: Porcine Vaccines Market , by End User, 2020-2027 (USD

Million)

Table 23 Europe: Porcine Vaccines Market , by Type, 2020-2027 (USD Million)

Table 24 Europe: Porcine Vaccines Market , by Disease Indication, 2020-2027 (USD

Million)

Table 25 Europe: Porcine Vaccines Market , by End User, 2020-2027 (USD Million)

Table 26 Western Europe: Porcine Vaccines Market , by Type, 2020-2027 (USD

Million)

Table 27 Western Europe: Porcine Vaccines Market , by Disease Indication, 2018–

2023 (USD Million)

Table 28 Western Europe: Porcine Vaccines Market , by End User, 2020-2027 (USD

Million)


Table 29 Eastern Europe: Porcine Vaccines Market , by Type, 2020-2027 (USD

Million)

Table 30 Eastern Europe: Porcine Vaccines Market , by Disease Indication, 2018–

2023 (USD Million)


Table 31 Eastern Europe: Porcine Vaccines Market , by End User, 2020-2027 (USD

Million)

Table 32 Asia-Pacific: Porcine Vaccines Market , by Type, 2020-2027 (USD

Million)

Table 33 Asia-Pacific: Porcine Vaccines Market , by Disease Indication, 2020-2027

(USD Million)

Table 34 Asia-Pacific: Porcine Vaccines Market , by End User, 2020-2027 (USD

Million)

Table 35 Middle East & Africa: Porcine Vaccines Market , by Type, 2020-2027

(USD Million)

Table 36 Middle East & Africa: Porcine Vaccines Market , by Disease Indication,

2020-2027 (USD Million)

Table 37 Middle East & Africa: Porcine Vaccines Market , by End User, 2020-2027

(USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Porcine Vaccines Market

Figure 3 Segmentation Market Dynamics for Global Porcine Vaccines Market

Figure 4 Global Porcine Vaccines Market Share, by Type, 2020

Figure 5 Global Porcine Vaccines Market Share, by Disease Indication, 2020

Figure 6 Global Porcine Vaccines Market Share, by End User, 2020

Figure 7 Global Porcine Vaccines Market Share, by Region, 2020

Figure 8 North America: Porcine Vaccines Market Share, by Country, 2020

Figure 9 Europe: Porcine Vaccines Market Share, by Country, 2020

Figure 10 Asia-Pacific: Porcine Vaccines Market Share, by Country, 2020

Figure 11 Middle East & Africa: Porcine Vaccines Market Share, by Country, 201

Figure 12 Global Porcine Vaccines Market : Company Share Analysis, 2020 (%)

Figure 13 Bayer AG: Key Financials

Figure 14 Bayer AG: Segmental Revenue

Figure 15 Bayer AG: Geographical Revenue

Figure 16 Bimeda, Inc.: Key Financials

Figure 17 Bimeda, Inc.: Segmental Revenue

Figure 18 Bimeda, Inc.: Geographical Revenue

Figure 19 Boehringer Ingelheim International GmbH: Key Financials

Figure 20 Boehringer Ingelheim International GmbH: Segmental Revenue

Figure 21 Boehringer Ingelheim International GmbH : Geographical Revenue

Figure 22 Ceva Sante Animale: Key Financials

Figure 23 Ceva Sante Animale: Segmental Revenue

Figure 24 Ceva Sante Animale: Geographical Revenue

Figure 25 Eli Lilly and Company: Key Financials

Figure 26 Eli Lilly and Company: Segmental Revenue

Figure 27 Eli Lilly and Company: Geographical Revenue

Figure 28 Merck & Co., Inc.: Key Financials

Figure 29 Merck & Co., Inc.: Segmental Revenue

Figure 30 Merck & Co., Inc.: Geographical Revenue

Figure 31 Sanofi S.A.: Key Financials

Figure 32 Sanofi S.A.: Segmental Revenue

Figure 33 Sanofi S.A: Geographical Revenue

Figure 34 Vetoquinol S.A.: Key Financials

Figure 35 Vetoquinol S.A.: Segmental Revenue

Figure 36 Vetoquinol S.A.: Geographical Revenue

Figure 37 Zoetis, Inc.: Key Financials

Figure 38 Zoetis, Inc.: Segmental Revenue

Figure 39 Zoetis, Inc.: Geographical Revenue

Figure 40 PBS Animal Health: Key Financials

Figure 42 PBS Animal Health: Segmental Revenue

Figure 43 PBS Animal Health: Geographical Revenue

Figure 44 Aptimmune: Key Financials

Figure 45 Aptimmune: Segmental Revenue

Figure 46 Aptimmune: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.